iressa

iressa

美 　英

• 网络易瑞沙；吉非替尼；艾瑞莎

例句

I would like you to imagine that you are presenting information about IRESSA to your peers.

现在假设您需要向您的同事阐述关于易瑞沙的一些信息。

Doctor, the profile that you just read is actually for (gefitinib) IRESSA.

医生，刚才您所阅读的简介其实就是（吉非替尼）易瑞沙。

What are your first thoughts about the potential indication for IRESSA (gefitinib) IRESSA? Do you agree? Do you think it is appropriate?

对于易瑞沙（吉非替尼）的潜在迹象有什么想法？您是否赞同？您认为它是否合适？

How would you use IRESSA? For which lines of therapy and for which patients? Why?

您会如何使用易瑞沙？会用于几线治疗？用于哪些患者？为什么？

Would you consider using IRESSA in patients who otherwise be suitable for chemotherapy? Why?

对于适用化疗的患者您是否会考虑使用易瑞沙？为什么？

Which statements would you choose to further develop your "story" to encompass the usage of Iressa in 2nd line treatment of advanced NSCLC?

为了更好的发展这个“故事”您会选择哪些描述，且能涵盖把易瑞沙作为晚期NSCLC患者的二线治疗方法？

The recommended daily dose of IRESSA is one 250 mg tablet with or without food.

建议的每日剂量易瑞沙是250毫克片剂或无食物。

Based on what you read, how likely would you be to use IRESSA as 1st line treatment in advanced NSCLC in your patients?

根据您刚才读的内容，您对于晚期NSCLC患者使用易瑞沙作为一线治疗的意愿有多大？

Clinical investigation of IRESSA in the treatment of patients with advanced refractory non-small cell lung cancer

IRESSA治疗晚期难治性非小细胞肺癌的临床研究

The molecularly targeted anticancer agent: The clinical benefit of iressa in the treatment of non-small-cell lung cancer

分子靶抗癌药：伊丽沙治疗非小细胞肺癌的临床效益

Iressa in the treatment of 24 cases of advanced non-small cell lung cancer patients who had failed to previous chemotherapy

易瑞沙在24例化疗后进展的晚期非小细胞肺癌中的作用

Adverse reaction monitoring and nursing care of patients taking Iressa to treat late non small-cell lung cancer

吉非替尼治疗晚期非小细胞肺癌不良反应的观察及护理

Treatment of iressa in advanced refractory non-small cell lung cancer: results in 53 patients

易瑞沙治疗晚期非小细胞肺癌53例疗效观察